Therapeutic Characterization of 131I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Characterization of 131I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma

Published:2023-06 Issue: Volume: Page:
ISSN:2095-8099
Container-title:Engineering
language:en
Short-container-title:Engineering

Author:

Fu Fengqing,Zheng Meng,Zhao Shandong,Wang Yan^ORCID,Huang Minzhou,Chen Hanqing,Huang Ziyi,Zhang Kaijie,Miao Liyan,Zhang Xueguang^ORCID

Publisher

Elsevier BV

Subject

General Engineering,Energy Engineering and Power Technology,Materials Science (miscellaneous),General Chemical Engineering,Environmental Engineering,General Computer Science

Reference40 articles.

1. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment;Gaspar;Int J Radiat Oncol Biol Phys,1992

2. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017;Ostrom;Neuro-oncol,2020

3. Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients;Reardon;Expert Rev Anticancer Ther,2007

4. Recent advances in the molecular understanding of glioblastoma;Bleeker;J Neurooncol,2012

5. Immunotherapy for glioma: current management and future application;Xu;Cancer Lett,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP